OTCMKTS:BSTG - Biostage Stock Price, News & Analysis

$2.76
+0.01 (+0.36 %)
(As of 09/17/2019 02:20 AM ET)
Today's Range
$2.76
Now: $2.76
$2.76
50-Day Range
$2.18
MA: $2.38
$2.90
52-Week Range
$0.75
Now: $2.76
$3.46
Volume470 shs
Average Volume2,884 shs
Market Capitalization$19.37 million
P/E RatioN/A
Dividend YieldN/A
Beta1.54
Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology combines a proprietary biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants. It is developing bioengineered organ implants, which addresses the damage of the esophagus, bronchus, and trachea due to cancer, infection, trauma, or congenital abnormalities. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BSTG
CUSIPN/A
Phone774-233-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$80,000.00
Book Value$0.35 per share

Profitability

Net Income$-7,530,000.00

Miscellaneous

Employees15
Market Cap$19.37 million
Next Earnings Date11/14/2019 (Estimated)
OptionableNot Optionable

Receive BSTG News and Ratings via Email

Sign-up to receive the latest news and ratings for BSTG and its competitors with MarketBeat's FREE daily newsletter.


Biostage (OTCMKTS:BSTG) Frequently Asked Questions

What is Biostage's stock symbol?

Biostage trades on the OTCMKTS under the ticker symbol "BSTG."

How were Biostage's earnings last quarter?

Biostage Inc (OTCMKTS:BSTG) released its quarterly earnings results on Tuesday, August, 13th. The company reported ($0.37) earnings per share for the quarter. View Biostage's Earnings History.

When is Biostage's next earnings date?

Biostage is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for Biostage.

Has Biostage been receiving favorable news coverage?

Media stories about BSTG stock have trended somewhat positive this week, according to InfoTrie. The research firm rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Biostage earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave news stories about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Biostage.

Who are some of Biostage's key competitors?

What other stocks do shareholders of Biostage own?

Who are Biostage's key executives?

Biostage's management team includes the folowing people:
  • Mr. James J. McGorry, CEO & Director (Age 63)
  • Mr. Thomas W. McNaughton, CFO & Sec. (Age 59)
  • Yu Hong, Pres (Age 46)
  • Ms. Ginger A. Abraham-Freel, Director of Quality & Operations
  • Dr. William L. Fodor Ph.D., Chief Scientific Officer (Age 60)

How do I buy shares of Biostage?

Shares of BSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Biostage's stock price today?

One share of BSTG stock can currently be purchased for approximately $2.76.

How big of a company is Biostage?

Biostage has a market capitalization of $19.37 million and generates $80,000.00 in revenue each year. Biostage employs 15 workers across the globe.View Additional Information About Biostage.

What is Biostage's official website?

The official website for Biostage is http://www.biostage.com/.

How can I contact Biostage?

Biostage's mailing address is 84 October Hill Road Suite 11, Holliston MA, 01746. The company can be reached via phone at 774-233-7300 or via email at [email protected]


MarketBeat Community Rating for Biostage (OTCMKTS BSTG)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  35 (Vote Outperform)
Underperform Votes:  20 (Vote Underperform)
Total Votes:  55
MarketBeat's community ratings are surveys of what our community members think about Biostage and other stocks. Vote "Outperform" if you believe BSTG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BSTG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Featured Article: Diluted Earnings Per Share

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel